ストックスクリーナーアプリを入手
0.4736
3.35%
-0.0164
アフターアワーズ：
.47
-0.0036
-0.76%
前日終値:
$0.49
開ける：
$0.48
24時間の取引高:
865.46K
Relative Volume:
0.40
時価総額：
$4.14M
収益：
$749.50K
当期純損益:
$-29.60M
株価収益率:
-0.00126
EPS:
-376.0263
ネットキャッシュフロー:
$-22.09M
1週間 パフォーマンス:
-19.15%
1か月 パフォーマンス:
-70.40%
6か月 パフォーマンス:
-99.49%
1年 パフォーマンス:
-99.82%
1日の値動き範囲:
$0.4529
$0.4879
1週間の範囲:
$0.4529
$0.59
52週間の値動き範囲:
$0.4529
$380.00
Aditxt Inc Stock (ADTX) Company Profile
Aditxt Inc (ADTX) 最新ニュース
Aditxt, Inc. Focuses on Growth Amid Nasdaq Compliance - TipRanks
ADTXAditxt, Inc. Latest Stock News & Market Updates - StockTitan
Aditxt receives positive FDA feedback on ATI-1801 development - Investing.com India
Evofem Biosciences enters agreements amid merger plans By Investing.com - Investing.com UK
ADTX stock plunges to 52-week low of $0.53 amid market challenges - Investing.com
Aditxt receives positive FDA feedback on ATI-1801 development By Investing.com - Investing.com UK
Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission - StockTitan
Appili Therapeutics’ FDA Alignment and Aditxt Acquisition - TipRanks
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission - The Manila Times
Aditxt Enters Major Investment Agreement with Evofem - TipRanks
Aditxt appoints Sylvia Hermina to board By Investing.com - Investing.com Canada
Sylvia Hermina Joins Aditxt's Board of Directors, Elevating Leadership with Broader Perspectives - Quantisnow
Aditxt appoints Sylvia Hermina to board - Investing.com
Aditxt, Inc. Appoints Sylvia Hermina to its Board of Directors - Marketscreener.com
Evofem Biosciences, Inc. announced that it has received $2.28 million in funding from Aditxt, Inc. - Marketscreener.com
Is Aditxt Inc (NASDAQ: ADTX) Doomed From The Get-Go? - Stocks Register
Evofem Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - Quantisnow
Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem - Quantisnow
ADTX stock touches 52-week low at $0.89 amid sharp decline - Investing.com UK
Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time - StockTitan
Aditxt shares sold by major stakeholder HRT Financial for $29,874 - Investing.com South Africa
ADTX stock touches 52-week low at $1.07 amid steep annual decline - Investing.com
ADTX stock touches 52-week low at $1.07 amid steep annual decline By Investing.com - Investing.com South Africa
Why Aditxt Inc Stock Might Make Sense If Bought Today - Stocks Register
There is no way Aditxt Inc (ADTX) can keep these numbers up - SETE News
Aditxt Inc (ADTX) requires closer examination - US Post News
Market Insight: Aditxt Inc (ADTX)’s Notable Drop, Closing at 1.16 - The Dwinnex
Aditxt Inc: Analyzing ADTX Stock Trends - The InvestChronicle
Aditxt CEO Clarifies NASDAQ Compliance and Capital Strategy - Yahoo Finance
InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Subsidiary Signs Agreement with Evofem Biosciences Inc. (OTCQB: EVFM) Involving Unique Endometriosis Diagnostic Test - MSN
Aditxt moves to acquire Appili Therapeutics - Investing.com India
Appili Therapeutics Corrects Shareholder Payout Terms - TipRanks
Aditxt moves to acquire Appili Therapeutics By Investing.com - Investing.com Canada
Appili Therapeutics – Press Release Correction - GlobeNewswire Inc.
Appili Therapeutics mails circular in connection with special meeting - TipRanks
Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval - StockTitan
Appili Therapeutics Nears Acquisition by Aditxt Inc. - TipRanks
Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders - The Manila Times
You might want to take a look at Aditxt Inc (ADTX) now - SETE News
Aditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight Time - Quantisnow
Aditxt faces Nasdaq delisting over share price rule By Investing.com - Investing.com South Africa
Aditxt faces Nasdaq delisting over share price rule - Investing.com India
Aditxt Inc: Navigating Market Fluctuations with a 0.18M Market Cap - The InvestChronicle
Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem - Quantisnow
Aditx Therapeutics stock hits 52-week low at $1.58 - Investing.com India
Aditx Therapeutics stock hits 52-week low at $1.58 By Investing.com - Investing.com Australia
Aditxt Inc (ADTX)’s stock price range in the last year - US Post News
Aditxt Inc (ADTX) 財務データ
収益
当期純利益
現金流量
EPS
Aditxt Inc (ADTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Oct 16 '24 |
Sale |
1.17 |
25,534 |
29,875 |
0 |
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):